You are viewing: Spain Humanized Mouse and Rat Model Market analysis

The Spain Humanized Mouse and Rat Model Market was valued at $3.9 Million in 2025 and projected to reach to $4.9 Million by 2030, representing a compound annual growth rate of 4.6%. Spain's humanized mouse and rat model market is positioned for steady growth as the country strengthens its position in European pharmaceutical research.

Spain Humanized Mouse and Rat Model Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Spain Humanized Mouse and Rat Model Market Trends and Insights

  • This moderate but steady growth reflects Spain's increasing investment in preclinical research infrastructure and pharmaceutical development capabilities.
  • Spain's biotech and pharmaceutical sectors are leveraging humanized animal models to accelerate drug discovery and development, particularly in oncology, immunology, and infectious disease research. The Spanish market benefits from strong academic research institutions and growing collaboration between public research centers and private pharmaceutical companies.
  • Spain's participation in European Union research initiatives and funding programs supports the adoption of advanced preclinical models.
  • By 2030, Spain is expected to maintain its position as a secondary but important market within Europe, driven by rising demand for personalized medicine research and regulatory requirements for preclinical safety testing..

Key Market Statistics

  • CAGR (2025-2030) 4.6% CAGR
  • Market Size, 2025 ~USD 3.9 Million
  • Forecast, 2030 ~USD 4.9 Million
  • Country Spain

Spain Humanized Mouse and Rat Model Market Overview

Market Valuation :

Spain's humanized mouse and rat model market is valued at $3.9 million in 2025, with steady growth projected to reach $4.9 million by 2030.

Growth Rate :

The Spanish market is expanding at a CAGR of 4.6%, reflecting moderate but consistent growth driven by increased preclinical research investments.

Biotech Infrastructure :

Spain's growing biotech and pharmaceutical sectors are increasingly adopting humanized animal models to accelerate drug development and reduce time-to-market.

Research Investment :

Spanish institutions are strengthening preclinical research capabilities through government funding and private sector collaboration, supporting market expansion.

Spain Humanized Mouse and Rat Model Market Dynamics

  • Increased government support for biotech innovation and rising collaboration between academic institutions and pharmaceutical companies are driving demand for advanced preclinical models.
  • Spanish CROs and research facilities are investing in humanized animal model technologies to meet regulatory requirements and improve drug efficacy predictions. The market will benefit from Spain's strategic location within the EU, enabling access to broader European research networks and funding opportunities.
  • As Spanish pharmaceutical companies expand their R&D pipelines and seek alternatives to traditional animal testing, humanized models will become increasingly integral to drug development strategies through 2030..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Spain's humanized mouse and rat model market is valued at $3.9 million in 2025 with a projected value of $4.9 million by 2030.
    • Spain experiences a 4.6% CAGR, reflecting moderate but consistent growth in preclinical research adoption.
    • Spain's market is driven by increased pharmaceutical R&D investment and EU-funded research initiatives.
    • Spain's academic institutions and biotech sector are key adopters of humanized animal models for drug development.

    Humanized Mouse and Rat Model Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS AND CDMOS) (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.2% from 2025 to 2030
    Largest Segment HUMANIZED MOUSE MODELS (Type)
    Market Size Base Year (Billions) ~USD 0.28 (2025)
    Revenue Forecast (Billions) ~USD 0.41 (2030)
    Segments Covered Type, End User, Application

    Spain Humanized Mouse and Rat Model Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Type

    • Blt Humanized Mouse Models
    • Cd34 Humanized Mouse Models
    • Cell-Based Humanized Mouse Models
    • Genetic Humanized Mouse Models
    • Humanized Mouse Models
    • Humanized Rat Models
    • Pbmc Humanized Mouse Models

    By End User

    • Academic & Research Institutes
    • Academic And Research Institutes
    • Contract Research Organizations And Contract Development And Manufacturing Organizations (Cros And Cdmos)
    • Cros & Cdmos
    • Cros And Cdmos
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical And Biotechnology Companies

    By Application

    • Hematopoiesis
    • Immunology And Infectious Diseases
    • Neuroscience
    • Oncology
    • Other Applications
    • Toxicology

    SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.670.660.680.690.710.720.730.741.8
    CROS AND CDMOS1.21.241.311.41.481.561.641.735.7
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES2.632.662.782.923.053.173.283.44.1
    TOTAL4.54.564.765.015.245.455.665.864.2

    Target Audience

    • Pharmaceutical Companies : Spanish and international pharma firms need market data to optimize R&D investments, identify local CRO partners, and plan preclinical research strategies in Spain.
    • Contract Research Organizations : Spanish and European CROs require market intelligence to benchmark capabilities, identify growth opportunities, and develop service offerings for humanized model research.
    • Biotech Startups : Spanish biotech companies need localized market insights to secure funding, plan product development timelines, and understand demand for humanized animal models.
    • Research Institutions : Spanish universities and research centers require market data to justify funding requests, identify collaboration opportunities, and align research programs with industry needs.
    • Investors & Venture Capital : VC firms and investors targeting Spanish biotech need market forecasts and growth drivers to evaluate investment opportunities in preclinical research infrastructure.

    Key Companies in the Spain Humanized Mouse and Rat Model Market

    CompanyHQOwnershipStrongest segments
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    THE JACKSON LABORATORYUnited StatesFoundation/Charitable InstitutionMouse breeding and colony management,Phenotyping, efficacy testing, and genetic research services,Genetic resources, software, and data,
    INOTIVUnited StatesPublic CompanyResearch Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
    GENOWAYFrancePublic CompanyCustom mouse models (KO/KI and humanized),Custom rat models,Engineered cell lines,
    JSR CORPORATIONJapanPrivate CompanyDigital Solutions (lithography, photoresists, CMP, display and packaging materials),Plastics / Synthetic Resins (ABS, AES, AS, ASA and related resins),Life Sciences (diagnostic and research reagents, bioprocess materials, drug discovery support),
    CHAMPIONS ONCOLOGY, INC.United StatesPublic CompanyTumorgraft / PDX-based translational oncology services,Personalized cancer care services,Lumin Bioinformatics and data-driven software,
    ONCODESIGN SERVICESFrancePublic CompanyPrecision oncology and immuno-oncology (OPM-101, OPM-102),Neurodegeneration (OPM-201, Parkinson’s),Radiotheranostic portfolio for digestive and pancreatic cancers,

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a public company founded in 1947 in the United States with 19,000 employees.

    THE JACKSON LABORATORY

    The Jackson Laboratory is a foundation-based charitable institution founded in 1929 in the United States with 2,100 employees.

    INOTIV

    Inotiv is a public company founded in 1974 in the United States with 1,996 employees.

    GENOWAY

    Genoway is a public company founded in 1999 in France with 157 employees.

    JSR CORPORATION

    JSR Corporation is a private company founded in 1948 in Japan with 7,997 employees.

    CHAMPIONS ONCOLOGY, INC.

    Champions Oncology, Inc. is a public company founded in 1985 in the United States with 214 employees.

    ONCODESIGN SERVICES

    Oncodesign Services is a public company founded in 1995 in France.

    Reasons to Buy this Report

    • Market-Specific Sizing : Access precise valuation data for Spain's humanized model market with verified 2025-2030 forecasts, enabling accurate budget allocation and investment decisions.
    • Competitive Landscape Intelligence : Understand Spain's unique market dynamics, local CRO capabilities, and regional pharmaceutical R&D trends to identify partnership and expansion opportunities.
    • Growth Driver Analysis : Identify key factors fueling Spain's 4.6% CAGR, including government funding initiatives, regulatory changes, and institutional research investments specific to the region.
    • Strategic Market Entry : Develop targeted go-to-market strategies for Spain by understanding local research infrastructure, customer preferences, and adoption barriers in preclinical research.
    • Regulatory & Compliance Insights : Navigate Spain's EU-aligned regulatory framework for animal models and preclinical testing with country-specific compliance requirements and best practices.

    Frequently asked questions

    What is the current size of Spain's humanized mouse and rat model market?

    Spain's humanized mouse and rat model market is valued at $3.9 million in 2025.

    What is the projected market size for Spain by 2030?

    Spain's market is forecast to reach $4.9 million by 2030.

    What is the growth rate for Spain's humanized animal model market?

    Spain's market is growing at a compound annual growth rate of 4.6% from 2025 to 2030.

    Which sectors are driving demand for humanized models in Spain?

    Spain's pharmaceutical, biotech, and academic research sectors are primary drivers, particularly in oncology, immunology, and infectious disease research.

    How does Spain's market compare to the global market?

    Spain's 4.6% CAGR is lower than the global 8.2% CAGR, positioning Spain as a secondary but growing market within Europe.

    RESEARCH METHODOLOGY

    The research study used secondary sources, directories, and databases to identify and collect valuable information to analyze the global humanized mouse and rat model market. Widespread interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size was estimated through secondary research (top-down and bottom-up), followed by data triangulation with inputs from industry experts to determine the final market size.

    Secondary Research

    Secondary research was used to identify and collect information for the technical, market-oriented, and commercial study of the humanized mouse and rat model market. The secondary sources used for this study include the American Association for Cancer Research (AACR), American Association for Laboratory Animal Science (AALAS), European Society for Medical Oncology (ESMO), European Association for Cancer Research (EACR), Humanized Mouse Resource (HMR), National Center for Biotechnology Information (NCBI), and Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

    Academic Journals and Company Websites; corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations were also used to obtain major information about key market players and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analyzed to determine the market size of the global humanized mouse and rat model market, which was further validated through primary research.

    Primary Research

    Primary research was conducted after acquiring basic knowledge about the global humanized mouse and rat model market through secondary research. A series of primary interviews were conducted with market experts from the demand side, including professionals from the pharmaceutical and biopharmaceutical industries and academic institutions. Additionally, interviews were held with individuals from the supply side, such as C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners. The primary interviews were conducted across North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants. This data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The breakdown of the primary respondents is given below.

    Humanized Mouse and Rat Model Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Top-down and bottom-up approaches were used to estimate and validate the total size of the humanized mouse and rat model market. These methods were also used extensively to estimate the size of various subsegments in the market.

    Humanized Mouse and Rat Model Market

    Data Triangulation

    After determining the market size from the above estimation process, the total market was divided into several segments and subsegments. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides.

    Market Definition

    A humanized mouse and rat model is an immunodeficient organism genetically engineered to study immune responses to drugs or identify potential disease targets. These models are widely used to study human diseases and genes. Researchers in both academia and industry, along with clinicians, extensively use humanized mouse and rat models in their research applications. Humanized mouse and rat models are beneficial tools for immuno-oncology and infectious disease research. They have improved the ability to predict human responses to new therapeutics in clinical development.

    Stakeholders

    • Research and consulting firms
    • Biopharmaceutical manufacturers
    • Pharmaceutical manufacturers
    • Mouse model and service companies
    • Government and private research institutes
    • Manufacturers and suppliers of animal care products
    • Clinical research organizations (CROs)
    • Academic and research institutes
    • Venture capitalists
    • Laboratory animal care associations
    • Public and private animal health agencies

    Report Objectives

     

    To define, describe, and forecast the humanized mouse and rat model market by type, application, end user, and region

    To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)

    • To analyze the micromarkets1 concerning individual growth trends, prospects, and contributions to the overall humanized mouse and rat model market
    • To assess the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments for North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
    • To profile the key players and analyze their market shares and core competencies2
    • To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

     

    Get the Full Humanized Mouse and Rat Model Market Report

    Full forecast, segment splits, and company analysis for all Humanized Mouse and Rat Model Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status